Clinical mass spectrometry finds wide application in clinical research and drug development for disease diagnosis, monitoring disease progression, drug metabolism studies etc. It helps in detection of trace level molecules present in biological samples like blood, urine etc. and provides accurate molecular weight information. The ability of mass spectrometers to perform multitask functions like identification, quantification and structural characterization has increased its demand in clinical settings. The Clinical Mass Spectrometry Market is estimated to be valued at US$ 6.37 Bn in 2023 and is expected to exhibit a CAGR of 26% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends propelling the growth of clinical mass spectrometry market is increasing adoption of LC-MS/MS systems for newborn screening. Newborn screening involves screening of all newborns for certain genetic, endocrine and metabolic disorders which if left untreated can lead to serious health issues or death. Mass spectrometry based newborn screening allows diagnosis of over 50 different disorders in a single sample analysis. Growing incidences of chronic and genetic diseases is driving the adoption of mass spectrometry for newborn screening procedures globally. Additionally, technological advancements improving resolution, throughput and ease of use of mass spectrometers is supporting their increased adoption in clinical research and disease diagnosis.
Porter’s Analysis
Threat of new entrants: New companies find it difficult to enter into the market as it requires heavy capital investments for R&D, manufacturing and distribution networks. They also face strong competition from existing key players.
Bargaining power of buyers: Buyers have moderate bargaining power as there are many established players providing similar clinical mass spectrometry devices. However, highly differentiated products increase switching costs for buyers.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power as key components can be substituted and players have multiple sourcing options to avoid dependence on single/few suppliers.
Threat of new substitutes: Threat of new substitutes is low as mass spectrometry technology provides unique capabilities for complex proteomic and metabolomic analysis that are difficult to substitute.
Competitive rivalry: Intense as key players compete on performance, pricing and aftersales support.
SWOT Analysis
Strength: Advanced technologies enabling high throughput screening and accurate detection of biomarkers. Wide applications in R&D, clinical diagnosis and treatment monitoring.
Weakness: High installation and maintenance costs limiting adoption in low resource settings. Require highly skilled workforce for operation.
Opportunity: Growing proteomic and metabolomic research driving demand. Rising incidence of cancers and other chronic diseases creating avenues.
Threats: Stringent regulatory approvals delaying new product launches. Economic slowdowns impacting research spending of pharma companies.
Key Takeaways
The global clinical mass spectrometry market is expected to witness high growth, exhibiting CAGR of 26% over the forecast period, due to increasing investments in proteomic and metabolomic research. Growing focus on precision medicine and drug development is also fueling the demand for clinical mass spectrometry devices for disease biomarker discovery and validation.
Regional analysis: North America dominates the global clinical mass spectrometry market currently due to presence of major players and advanced research infrastructure. Asia Pacific is anticipated to witness fastest growth over the forecast period supported by increasing healthcare expenditure, rising affinity towards advanced technologies, and growing contract research activities in countries like China and India.
Key players operating in the clinical mass spectrometry market are SCIEX AB(US), Thermo Fisher Scientific (US), Agilent Technologies (US), Waters Corporation (US), PerkinElmer Inc. (US), Shimadzu Corporation (Japan), Bruker Corporation (US), Analytik Jena (Germany), JEOL Ltd. (Japan), Hiden Analytical (UK), and MKS Instruments (US), among others. Major players are focusing on new product development and geographical expansion to consolidate their market shares.
This report studies the Clinical Mass Spectrometry market, covering market size for segment by type (LC-MS, GC-MS, etc.
), by Sales Channel (Direct Channel, Distribution Channel), by player (Thermo Fisher, AB Sciex (Danaher), Waters, Agilent, Bruker, etc.)
and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
Since the pandemic of COVID-19 is still raging, The COVID-19 will have a certain impact on this global market.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries.
Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-clinical-mass-spectrometry-2021-2030-722 This report provides detailed historical analysis of global market for Clinical Mass Spectrometry from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors.
Report on World Clinical Mass Spectrometry Market by Product Type, Market, Players and Regions-Forecast to 2025 by DecisionDatabases.comClinical Mass Spectrometry market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability.The industry report lists the leading competitors and provides the insights strategic industry analysis of the key factors influencing the market.The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/46972-world-clinical-mass-spectrometry-market-reportThe players mentioned in our reportThermo FisherAB Sciex (Danaher)AgilentBrukerPerkin ElmerShidmazuWatersGlobal Clinical Mass Spectrometry Market: Product Segment AnalysisLC-MSGC-MSGlobal Clinical Mass Spectrometry Market: Application Segment AnalysisClinical DiagnosticsClinical ResearchGlobal Clinical Mass Spectrometry Market: Regional Segment AnalysisUSAEuropeSouth East AsiaChinaIndiaDownload Free Sample Report of World Clinical Mass Spectrometry Market @ https://www.decisiondatabases.com/contact/download-sample-46972There are 10 Chapters to deeply display the World Clinical Mass Spectrometry market.Chapter 1 About the Clinical Mass Spectrometry IndustryChapter 2 World Market Competition LandscapeChapter 3 World Clinical Mass Spectrometry Market shareChapter 4 Supply Chain AnalysisChapter 5 Company ProfilesChapter 6 Globalisation & TradeChapter 7 Distributors and CustomersChapter 8 Import, Export, Consumption and Consumption Value by Major CountriesChapter 9 World Clinical Mass Spectrometry Market Forecast through 2025Chapter 10 Key success factors and Market OverviewPurchase the complete World Clinical Mass Spectrometry Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-46972Other Reports by DecisionDatabases.com:World Biomass Stove Market Research Report 2022 (covering USA, Europe, China, Japan, India, South East Asia and etc)World Biomass Gasifier Market Research Report 2022 (covering USA, Europe, China, Japan, India, South East Asia and etc)About-Us:DecisionDatabases.com is a global business research report provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
